Structure

Physi-Chem Properties

Molecular Weight:  486.17
Volume:  497.252
LogP:  4.12
LogD:  3.363
LogS:  -4.068
# Rotatable Bonds:  5
TPSA:  130.61
# H-Bond Aceptor:  7
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.225
Synthetic Accessibility Score:  4.081
Fsp3:  0.172
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.877
MDCK Permeability:  5.8024425015901215e-06
Pgp-inhibitor:  0.66
Pgp-substrate:  0.028
Human Intestinal Absorption (HIA):  0.779
20% Bioavailability (F20%):  0.993
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.006
Plasma Protein Binding (PPB):  96.3773193359375%
Volume Distribution (VD):  0.623
Pgp-substrate:  3.592176675796509%

ADMET: Metabolism

CYP1A2-inhibitor:  0.201
CYP1A2-substrate:  0.613
CYP2C19-inhibitor:  0.622
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.821
CYP2C9-substrate:  0.978
CYP2D6-inhibitor:  0.638
CYP2D6-substrate:  0.692
CYP3A4-inhibitor:  0.852
CYP3A4-substrate:  0.22

ADMET: Excretion

Clearance (CL):  10.088
Half-life (T1/2):  0.803

ADMET: Toxicity

hERG Blockers:  0.267
Human Hepatotoxicity (H-HT):  0.095
Drug-inuced Liver Injury (DILI):  0.04
AMES Toxicity:  0.187
Rat Oral Acute Toxicity:  0.549
Maximum Recommended Daily Dose:  0.938
Skin Sensitization:  0.957
Carcinogencity:  0.026
Eye Corrosion:  0.003
Eye Irritation:  0.898
Respiratory Toxicity:  0.133

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC237424

Natural Product ID:  NPC237424
Common Name*:   Caragasinin A
IUPAC Name:   (1R,2S,3R)-3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-1-[(R)-(4-hydroxyphenyl)-methoxymethyl]-2,3-dihydro-1H-indene-4,6-diol
Synonyms:   Caragasinin A
Standard InCHIKey:  XPDHVQUZVFHQNW-DZXSPZCNSA-N
Standard InCHI:  InChI=1S/C29H26O7/c1-36-29(16-4-8-19(31)9-5-16)28-23-13-22(34)14-24(35)27(23)26(17-10-20(32)12-21(33)11-17)25(28)15-2-6-18(30)7-3-15/h2-14,25-26,28-35H,1H3/t25-,26-,28-,29-/m0/s1
SMILES:  CO[C@H]([C@H]1c2cc(O)cc(c2[C@H]([C@@H]1c1ccc(cc1)O)c1cc(O)cc(c1)O)O)c1ccc(cc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1939064
PubChem CID:   56950653
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000253] Stilbenes

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28914 Caragana sinica Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[22209460]
NPO28914 Caragana sinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28914 Caragana sinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28914 Caragana sinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO28914 Caragana sinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO28914 Caragana sinica Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1 Others Radical scavenging activity IC50 = 66700.0 nM PMID[501237]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 34700.0 nM PMID[501237]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC237424 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC238168
0.9274 High Similarity NPC120172
0.9219 High Similarity NPC471519
0.9219 High Similarity NPC471518
0.9127 High Similarity NPC97578
0.9091 High Similarity NPC11727
0.9091 High Similarity NPC15109
0.9077 High Similarity NPC473309
0.9 High Similarity NPC254000
0.8984 High Similarity NPC9292
0.8984 High Similarity NPC145659
0.8906 High Similarity NPC113495
0.8832 High Similarity NPC277784
0.8824 High Similarity NPC174787
0.8824 High Similarity NPC182509
0.8824 High Similarity NPC213607
0.8806 High Similarity NPC125579
0.8788 High Similarity NPC471517
0.8788 High Similarity NPC282508
0.8741 High Similarity NPC141717
0.8667 High Similarity NPC258780
0.8667 High Similarity NPC37410
0.8662 High Similarity NPC148516
0.8662 High Similarity NPC177172
0.8662 High Similarity NPC107862
0.8662 High Similarity NPC122980
0.8662 High Similarity NPC180605
0.8633 High Similarity NPC163508
0.8633 High Similarity NPC173203
0.8603 High Similarity NPC133463
0.8603 High Similarity NPC170328
0.8603 High Similarity NPC472647
0.8603 High Similarity NPC191462
0.8603 High Similarity NPC472649
0.8603 High Similarity NPC206525
0.8603 High Similarity NPC472648
0.8601 High Similarity NPC218801
0.8593 High Similarity NPC473107
0.8593 High Similarity NPC476615
0.8593 High Similarity NPC476617
0.8593 High Similarity NPC476616
0.8583 High Similarity NPC69006
0.8571 High Similarity NPC15659
0.8571 High Similarity NPC304894
0.8561 High Similarity NPC311293
0.8561 High Similarity NPC148366
0.855 High Similarity NPC170485
0.8542 High Similarity NPC233886
0.8542 High Similarity NPC157081
0.8542 High Similarity NPC105073
0.8542 High Similarity NPC224528
0.854 High Similarity NPC71465
0.854 High Similarity NPC472646
0.8529 High Similarity NPC472370
0.8519 High Similarity NPC469610
0.8519 High Similarity NPC473665
0.8516 High Similarity NPC102639
0.8511 High Similarity NPC149633
0.8507 High Similarity NPC8899
0.8483 Intermediate Similarity NPC120633
0.8483 Intermediate Similarity NPC473018
0.8467 Intermediate Similarity NPC471522
0.8451 Intermediate Similarity NPC176804
0.8451 Intermediate Similarity NPC71686
0.8444 Intermediate Similarity NPC469611
0.8438 Intermediate Similarity NPC3239
0.8438 Intermediate Similarity NPC282255
0.8421 Intermediate Similarity NPC215300
0.8417 Intermediate Similarity NPC472090
0.8417 Intermediate Similarity NPC472092
0.8417 Intermediate Similarity NPC472091
0.8417 Intermediate Similarity NPC273623
0.8406 Intermediate Similarity NPC94994
0.8406 Intermediate Similarity NPC470307
0.8406 Intermediate Similarity NPC470308
0.8397 Intermediate Similarity NPC228503
0.8397 Intermediate Similarity NPC138248
0.8392 Intermediate Similarity NPC237546
0.8392 Intermediate Similarity NPC231712
0.8392 Intermediate Similarity NPC224921
0.8392 Intermediate Similarity NPC112819
0.8392 Intermediate Similarity NPC133209
0.8392 Intermediate Similarity NPC111134
0.8392 Intermediate Similarity NPC242774
0.8392 Intermediate Similarity NPC6702
0.8385 Intermediate Similarity NPC255026
0.8385 Intermediate Similarity NPC174977
0.8382 Intermediate Similarity NPC185777
0.8357 Intermediate Similarity NPC472089
0.8346 Intermediate Similarity NPC53781
0.8346 Intermediate Similarity NPC473221
0.8333 Intermediate Similarity NPC329836
0.8333 Intermediate Similarity NPC105718
0.8333 Intermediate Similarity NPC105031
0.8333 Intermediate Similarity NPC278955
0.8308 Intermediate Similarity NPC476633
0.8298 Intermediate Similarity NPC183709
0.8298 Intermediate Similarity NPC472088
0.8298 Intermediate Similarity NPC472087
0.8286 Intermediate Similarity NPC22317
0.8284 Intermediate Similarity NPC47283
0.8284 Intermediate Similarity NPC38017
0.8284 Intermediate Similarity NPC39064
0.8271 Intermediate Similarity NPC50315
0.8271 Intermediate Similarity NPC230479
0.8271 Intermediate Similarity NPC26879
0.8271 Intermediate Similarity NPC283049
0.8271 Intermediate Similarity NPC82299
0.8268 Intermediate Similarity NPC261973
0.8261 Intermediate Similarity NPC313081
0.8254 Intermediate Similarity NPC107240
0.824 Intermediate Similarity NPC473521
0.8239 Intermediate Similarity NPC469630
0.8235 Intermediate Similarity NPC472590
0.8235 Intermediate Similarity NPC118114
0.8235 Intermediate Similarity NPC12875
0.8235 Intermediate Similarity NPC228369
0.8235 Intermediate Similarity NPC129106
0.8235 Intermediate Similarity NPC196765
0.8235 Intermediate Similarity NPC476166
0.8235 Intermediate Similarity NPC17343
0.8235 Intermediate Similarity NPC206224
0.8235 Intermediate Similarity NPC164574
0.8235 Intermediate Similarity NPC129784
0.8235 Intermediate Similarity NPC150011
0.8235 Intermediate Similarity NPC280653
0.8235 Intermediate Similarity NPC236014
0.8235 Intermediate Similarity NPC300875
0.8235 Intermediate Similarity NPC268917
0.8235 Intermediate Similarity NPC207892
0.8217 Intermediate Similarity NPC121866
0.8214 Intermediate Similarity NPC55947
0.8214 Intermediate Similarity NPC184613
0.8214 Intermediate Similarity NPC20210
0.8207 Intermediate Similarity NPC52161
0.8207 Intermediate Similarity NPC162751
0.8203 Intermediate Similarity NPC33270
0.8203 Intermediate Similarity NPC69261
0.8203 Intermediate Similarity NPC474933
0.8203 Intermediate Similarity NPC476266
0.8201 Intermediate Similarity NPC234952
0.8195 Intermediate Similarity NPC476653
0.8194 Intermediate Similarity NPC215678
0.8194 Intermediate Similarity NPC14468
0.8194 Intermediate Similarity NPC211758
0.8194 Intermediate Similarity NPC87794
0.8194 Intermediate Similarity NPC274454
0.8189 Intermediate Similarity NPC246760
0.8189 Intermediate Similarity NPC84999
0.8188 Intermediate Similarity NPC296915
0.8188 Intermediate Similarity NPC225696
0.8188 Intermediate Similarity NPC198154
0.8188 Intermediate Similarity NPC97834
0.8188 Intermediate Similarity NPC223008
0.8188 Intermediate Similarity NPC115335
0.8182 Intermediate Similarity NPC76465
0.8182 Intermediate Similarity NPC38761
0.8175 Intermediate Similarity NPC13005
0.8175 Intermediate Similarity NPC176730
0.8175 Intermediate Similarity NPC123175
0.8162 Intermediate Similarity NPC470225
0.8162 Intermediate Similarity NPC126836
0.8162 Intermediate Similarity NPC27187
0.8151 Intermediate Similarity NPC290695
0.8151 Intermediate Similarity NPC106524
0.8148 Intermediate Similarity NPC53986
0.8148 Intermediate Similarity NPC471064
0.8148 Intermediate Similarity NPC38664
0.8143 Intermediate Similarity NPC266006
0.8138 Intermediate Similarity NPC153182
0.8138 Intermediate Similarity NPC174251
0.8134 Intermediate Similarity NPC471215
0.8134 Intermediate Similarity NPC262573
0.8129 Intermediate Similarity NPC69029
0.8129 Intermediate Similarity NPC10314
0.8129 Intermediate Similarity NPC200557
0.8129 Intermediate Similarity NPC108198
0.8129 Intermediate Similarity NPC294884
0.8129 Intermediate Similarity NPC158142
0.8125 Intermediate Similarity NPC54507
0.8125 Intermediate Similarity NPC203113
0.8125 Intermediate Similarity NPC141090
0.8125 Intermediate Similarity NPC150624
0.8125 Intermediate Similarity NPC229147
0.8125 Intermediate Similarity NPC85292
0.8121 Intermediate Similarity NPC473365
0.8112 Intermediate Similarity NPC274721
0.8112 Intermediate Similarity NPC135767
0.8112 Intermediate Similarity NPC155392
0.8112 Intermediate Similarity NPC184607
0.8108 Intermediate Similarity NPC233467
0.8106 Intermediate Similarity NPC36016
0.8106 Intermediate Similarity NPC18128
0.8106 Intermediate Similarity NPC100099
0.8106 Intermediate Similarity NPC57199
0.8106 Intermediate Similarity NPC77789
0.8102 Intermediate Similarity NPC162801
0.8102 Intermediate Similarity NPC181497
0.8102 Intermediate Similarity NPC15543
0.8102 Intermediate Similarity NPC244888

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC237424 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8561 High Similarity NPD4908 Phase 1
0.8433 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8074 Intermediate Similarity NPD2861 Phase 2
0.803 Intermediate Similarity NPD1610 Phase 2
0.7863 Intermediate Similarity NPD3091 Approved
0.7826 Intermediate Similarity NPD4625 Phase 3
0.7826 Intermediate Similarity NPD3027 Phase 3
0.7794 Intermediate Similarity NPD3094 Phase 2
0.7761 Intermediate Similarity NPD3092 Approved
0.7727 Intermediate Similarity NPD1548 Phase 1
0.7717 Intermediate Similarity NPD4750 Phase 3
0.7671 Intermediate Similarity NPD3892 Phase 2
0.766 Intermediate Similarity NPD1613 Approved
0.766 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD4749 Approved
0.7647 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7612 Intermediate Similarity NPD3095 Discontinued
0.7609 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7594 Intermediate Similarity NPD7741 Discontinued
0.7581 Intermediate Similarity NPD846 Approved
0.7581 Intermediate Similarity NPD940 Approved
0.7518 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1242 Phase 1
0.7482 Intermediate Similarity NPD4624 Approved
0.7481 Intermediate Similarity NPD4059 Approved
0.7468 Intermediate Similarity NPD7199 Phase 2
0.7429 Intermediate Similarity NPD5736 Approved
0.7429 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD3020 Approved
0.7413 Intermediate Similarity NPD3620 Phase 2
0.7413 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD7041 Phase 2
0.74 Intermediate Similarity NPD7213 Phase 3
0.74 Intermediate Similarity NPD7212 Phase 2
0.7391 Intermediate Similarity NPD5327 Phase 3
0.7375 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD5735 Approved
0.7358 Intermediate Similarity NPD6959 Discontinued
0.7355 Intermediate Similarity NPD37 Approved
0.7353 Intermediate Similarity NPD3019 Approved
0.7351 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD7447 Phase 1
0.731 Intermediate Similarity NPD4097 Suspended
0.731 Intermediate Similarity NPD6353 Approved
0.7308 Intermediate Similarity NPD3021 Approved
0.7308 Intermediate Similarity NPD3022 Approved
0.7292 Intermediate Similarity NPD4060 Phase 1
0.7292 Intermediate Similarity NPD4140 Approved
0.7287 Intermediate Similarity NPD2342 Discontinued
0.7286 Intermediate Similarity NPD4339 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD7390 Discontinued
0.7261 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7237 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD6234 Discontinued
0.723 Intermediate Similarity NPD5763 Approved
0.723 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.723 Intermediate Similarity NPD5762 Approved
0.7226 Intermediate Similarity NPD2932 Approved
0.7222 Intermediate Similarity NPD6663 Approved
0.7215 Intermediate Similarity NPD4965 Approved
0.7215 Intermediate Similarity NPD7768 Phase 2
0.7215 Intermediate Similarity NPD4966 Approved
0.7215 Intermediate Similarity NPD4967 Phase 2
0.72 Intermediate Similarity NPD3750 Approved
0.72 Intermediate Similarity NPD7466 Approved
0.7183 Intermediate Similarity NPD3018 Phase 2
0.7181 Intermediate Similarity NPD7037 Approved
0.7177 Intermediate Similarity NPD2860 Approved
0.7177 Intermediate Similarity NPD2859 Approved
0.7172 Intermediate Similarity NPD2238 Phase 2
0.7162 Intermediate Similarity NPD6099 Approved
0.7162 Intermediate Similarity NPD5405 Approved
0.7162 Intermediate Similarity NPD5406 Approved
0.7162 Intermediate Similarity NPD6100 Approved
0.7162 Intermediate Similarity NPD5404 Approved
0.7162 Intermediate Similarity NPD5408 Approved
0.7153 Intermediate Similarity NPD3764 Approved
0.7153 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7635 Approved
0.7123 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD5124 Phase 1
0.7113 Intermediate Similarity NPD6584 Phase 3
0.7099 Intermediate Similarity NPD7229 Phase 3
0.7097 Intermediate Similarity NPD2933 Approved
0.7097 Intermediate Similarity NPD2934 Approved
0.7095 Intermediate Similarity NPD1510 Phase 2
0.709 Intermediate Similarity NPD5283 Phase 1
0.7067 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD7228 Approved
0.7029 Intermediate Similarity NPD4093 Discontinued
0.7021 Intermediate Similarity NPD2982 Phase 2
0.7021 Intermediate Similarity NPD2983 Phase 2
0.7 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD422 Phase 1
0.7 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.6994 Remote Similarity NPD6232 Discontinued
0.6988 Remote Similarity NPD5844 Phase 1
0.6984 Remote Similarity NPD288 Approved
0.6981 Remote Similarity NPD7819 Suspended
0.6981 Remote Similarity NPD2393 Clinical (unspecified phase)
0.698 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6978 Remote Similarity NPD4626 Approved
0.697 Remote Similarity NPD7473 Discontinued
0.6968 Remote Similarity NPD6273 Approved
0.6963 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6959 Remote Similarity NPD2157 Approved
0.6957 Remote Similarity NPD3749 Approved
0.6954 Remote Similarity NPD1549 Phase 2
0.695 Remote Similarity NPD2981 Phase 2
0.6939 Remote Similarity NPD1240 Approved
0.6929 Remote Similarity NPD3023 Approved
0.6929 Remote Similarity NPD3026 Approved
0.6918 Remote Similarity NPD1934 Approved
0.6918 Remote Similarity NPD6812 Clinical (unspecified phase)
0.6917 Remote Similarity NPD5451 Approved
0.6913 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6909 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6909 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6909 Remote Similarity NPD6166 Phase 2
0.6909 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6908 Remote Similarity NPD6674 Discontinued
0.6906 Remote Similarity NPD3024 Approved
0.6906 Remote Similarity NPD3025 Approved
0.6905 Remote Similarity NPD844 Approved
0.6903 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6903 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6903 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6901 Remote Similarity NPD6582 Phase 2
0.6901 Remote Similarity NPD6583 Phase 3
0.6899 Remote Similarity NPD4380 Phase 2
0.6892 Remote Similarity NPD3657 Discovery
0.6892 Remote Similarity NPD6355 Discontinued
0.6887 Remote Similarity NPD7266 Discontinued
0.6867 Remote Similarity NPD7033 Discontinued
0.6867 Remote Similarity NPD7743 Approved
0.6867 Remote Similarity NPD3748 Approved
0.6867 Remote Similarity NPD7742 Approved
0.6863 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6863 Remote Similarity NPD7003 Approved
0.6861 Remote Similarity NPD6671 Approved
0.6857 Remote Similarity NPD5125 Phase 3
0.6857 Remote Similarity NPD5126 Approved
0.6857 Remote Similarity NPD2286 Discontinued
0.6857 Remote Similarity NPD5238 Clinical (unspecified phase)
0.6855 Remote Similarity NPD7411 Suspended
0.6853 Remote Similarity NPD6696 Suspended
0.6846 Remote Similarity NPD2568 Approved
0.6846 Remote Similarity NPD1607 Approved
0.6842 Remote Similarity NPD8054 Approved
0.6842 Remote Similarity NPD8053 Approved
0.6835 Remote Similarity NPD4005 Discontinued
0.6835 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6831 Remote Similarity NPD2232 Approved
0.6831 Remote Similarity NPD2233 Approved
0.6831 Remote Similarity NPD2230 Approved
0.6825 Remote Similarity NPD1432 Clinical (unspecified phase)
0.6822 Remote Similarity NPD289 Clinical (unspecified phase)
0.6821 Remote Similarity NPD2796 Approved
0.6803 Remote Similarity NPD6798 Discontinued
0.6795 Remote Similarity NPD2532 Approved
0.6795 Remote Similarity NPD2534 Approved
0.6795 Remote Similarity NPD2533 Approved
0.6795 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6786 Remote Similarity NPD5691 Approved
0.6761 Remote Similarity NPD3705 Approved
0.6761 Remote Similarity NPD1201 Approved
0.6757 Remote Similarity NPD6405 Approved
0.6757 Remote Similarity NPD6407 Approved
0.6755 Remote Similarity NPD4108 Discontinued
0.6753 Remote Similarity NPD8166 Discontinued
0.675 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6748 Remote Similarity NPD7833 Phase 2
0.6748 Remote Similarity NPD7831 Phase 2
0.6748 Remote Similarity NPD7832 Clinical (unspecified phase)
0.6746 Remote Similarity NPD845 Approved
0.6739 Remote Similarity NPD709 Approved
0.6736 Remote Similarity NPD1876 Approved
0.6736 Remote Similarity NPD8651 Approved
0.6736 Remote Similarity NPD1283 Approved
0.6727 Remote Similarity NPD8127 Discontinued
0.6725 Remote Similarity NPD8453 Clinical (unspecified phase)
0.6711 Remote Similarity NPD2935 Discontinued
0.6706 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6691 Remote Similarity NPD228 Approved
0.669 Remote Similarity NPD2797 Approved
0.669 Remote Similarity NPD1470 Approved
0.6688 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6688 Remote Similarity NPD3638 Discontinued
0.6687 Remote Similarity NPD3787 Discontinued
0.6687 Remote Similarity NPD3882 Suspended
0.6686 Remote Similarity NPD8156 Discontinued
0.6667 Remote Similarity NPD6746 Phase 2
0.6667 Remote Similarity NPD5494 Approved
0.6667 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8455 Phase 2
0.6667 Remote Similarity NPD6002 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data